The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

The main indication for these products is as a first-line treatment for mild axillary hyperhidrosis. Oral anticholinergic agents such as glycopyrrolate or amitriptyline represent the main systemic ...

Introduction: Axillary hyperhidrosis can be a source of social isolation and embarrassment. The available treatments are either ineffective or have intolerable side effects. The search for a ...

Botox is one of the significant advances in dealing with hyperhidrosis: a practical, noninvasive, and long-term solution to a ...

Unfortunately, the authors do not differentiate between individual techniques in the section on local surgical techniques for axillary hyperhidrosis. Curettage and liposuction are mentioned ...

This development is part of Botanix’s strategy to expand payer coverage, now reaching over 110 million commercial lives, for its novel treatment targeting primary axillary hyperhidrosis, a condition ...

Botanix Pharmaceuticals Limited (AU:BOT) has released an update. Botanix Pharmaceuticals Limited is set to make waves in the ...

Having attained US Food & Drug Administration approval, Botanix is in the throes of a US rollout of Sofdra, its treatment for ...

Botanix Pharmaceuticals Limited is set to make waves in the dermatology market as it prepares to launch Sofdra, the first FDA-approved treatment for axillary hyperhidrosis. With an expanded team ...